Garay Arpa
- SEC CIK
- 0001916360
No open-market purchases or sales filed in the past year.
Current role at each company
- MRNA Moderna, Inc.Chief Commercial Officeras of Dec 7, 2023
- MRK Merck & Co., Inc.SVP Human Health Global Mktg.as of May 5, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Garay Arpa as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRNA Moderna, Inc.
Chief Commercial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 (view filing) | Dec 6 | 1 day | Garay ArpaChief Commercial Officer | SSale | −564 | $78.34 | −$44.2K | −13.3%3.69K after | 10b5-1 |
| Sep 7, 2023 (view filing) | Sep 6 | 1 day | Garay ArpaChief Commercial Officer | SSale | −574 | $108.40 | −$62.2K | −15.6%3.11K after | 10b5-1 |
| Jun 7, 2023 (view filing) | Jun 6 | 1 day | Garay ArpaChief Commercial Officer | SSale | −2.29K | $125.75 | −$288.0K | −47.3%2.55K after | 10b5-1 |